Clicky

Organon & Co.(OGN) News

Date Title
Jun 27 Organon (OGN) Stock Sinks As Market Gains: What You Should Know
Jun 26 5 Must-Read Analyst Questions From Organon’s Q1 Earnings Call
Jun 25 Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
Jun 24 Organon (OGN) Outpaces Stock Market Gains: What You Should Know
Jun 17 All You Need to Know About Organon (OGN) Rating Upgrade to Buy
Jun 17 OGN or DOCS: Which Is the Better Value Stock Right Now?
May 27 US Food and Drug Administration (FDA) Grants Interchangeability Designation to Samsung Bioepis and Organon HADLIMA™ (adalimumab-bwwd) Injection
May 9 CEO & Director of Organon Picks Up 14% More Stock
May 7 Organon (NYSE:OGN) Reports Decreased Earnings Affecting Investor Sentiment
May 7 Organon & Co. (NYSE:OGN) Goes Ex-Dividend Soon
May 2 Organon price target lowered to $10 from $11 at BofA
Apr 2 Why Organon (OGN) Could Beat Earnings Estimates Again
Apr 1 Organon Acquires TOFIDENCE™ (tocilizumab-bavi), a Commercialized Biosimilar to ACTEMRA® (tocilizumab) Injection, for Intravenous Infusion in the U.S.
Feb 15 Organon Full Year 2024 Earnings: EPS Misses Expectations
Feb 13 Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2024
Jan 28 An excellent week for Organon & Co.'s (NYSE:OGN) institutional owners who own 83% as one-year returns inch higher
Jan 23 Organon To Report Fourth Quarter and Full Year 2024 Results and Host Conference Call on February 13, 2025
Oct 9 Organon (OGN) Loses -9.91% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Oct 9 Organon to Report Third Quarter 2024 Results and Host Conference Call on October 31, 2024
Oct 8 Organon Canada Promotes Geneviève Gauthier as Executive Director, Corporate Affairs and Community Engagement and Appoints Jeffrey Malawski as Executive Director, Women's Health and Established Brands